Vimarsana
Biggest News Aggregation in the World

Page 16 - Pathology Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pathology Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pathology Lab Today - Breaking & Trending Today

Food Drive For Abraham's Tent This Sunday Sept. 25 - Vimarsana News

Food Drive For Abraham's Tent This Sunday Sept. 25

Here is how you can help.

Physicians Realty Trust Announces Acquisition of Calko Medical Center, in Brooklyn, New York, for $81.5 Million - Vimarsana News

Physicians Realty Trust Announces Acquisition of Calko Medical Center, in Brooklyn, New York, for $81.5 Million

Physicians Realty Trust , through a joint venture with Dallas, Texas based MedProperties Realty Advisors, LLC is proud to announce the closing of the acquisition of Calko Medical Center. This... | September 13, 2022

Roche's VENTANA PD-L1 (SP263) Assay receives CE IVD approval to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo - Vimarsana News

Roche's VENTANA PD-L1 (SP263) Assay receives CE IVD approval to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo

The VENTANA PD-L1 (SP263) Assay helps determine which patients with non-small cell lung cancer may be eligible for treatment with Libtayo monotherapy1 based on...

Roche's VENTANA PD-L1 (SP263) test gains CE label expansion as a companion diagnostic to identify non-small cell lung cancer patients eligible for Tecentriq - Vimarsana News

Roche's VENTANA PD-L1 (SP263) test gains CE label expansion as a companion diagnostic to identify non-small cell lung cancer patients eligible for Tecentriq

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced CE label expansion of the VENTANA PD-L1 (SP263) Assay in non-small cell lung cancer (NSCLC)...

F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022 - Vimarsana News

F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022

Basel, 21 July 2022 Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Division sales increase 3%; continued strong demand for new medicines to treat severe